Name: 1-Phenylcyclohexylamine
Type: Psychoactive compound
AKA: PCP precursor
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile (IUPAC name)
|
IV. History
1-Phenylcyclohexylamine, a chemical related to psychoactive substances, was developed for research purposes. It is studied for its effects on the central nervous system and its potential uses in medicine.
|
V. Legal Information
1-Phenylcyclohexylamine, a dissociative anesthetic, is not widely regulated today but is often controlled under analogue laws due to its structural similarity to PCP. In the US, it is illegal under the Federal Analog Act. Many countries have similar controls. The UNODC monitors new psychoactive substances, emphasizing the need for regulation. Trends show increasing measures to prevent misuse.
US Federal Schedule - II
Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
1-Phenylcyclohexylamine is a psychoactive compound with stimulant and dissociative properties. It acts as an upper, causing increased energy and altered perception. Short-term use can enhance mood and perception, but long-term use may result in psychological issues and potential dependency. Overdose risks include severe agitation and dissociative effects. Safe use requires cautious dosing and awareness of its effects. Recent studies investigate its psychoactive properties and potential health risks. |
VII. Psychological Effects
1-Phenylcyclohexylamine, a PCP analog, affects mood and cognition. Immediate effects include euphoria and altered perception. Long-term use may result in severe mood disorders, psychosis, and cognitive impairments. Recent studies highlight its potent effects and psychological risks similar to PCP, including severe mental health issues.
|
VIII. Culture
1-Phenylcyclohexylamine is a research chemical with stimulant properties, classifying it as an upper. Short-term use increases alertness and energy, while long-term effects are not well-documented. Overdose risks are moderate, potentially causing severe agitation and cardiovascular issues. Safe dosages are not well-established, with lower doses advised. Recent research focuses on its psychoactive potential and health risks. Physical effects may include increased heart rate, elevated blood pressure, and potential for severe agitation.
|